Calamos Advisors’s Stereotaxis STXS Stock Holding History

Calamos Advisors’s Portfolio STXS Stock Details STXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-660,818	Closed	-$6.37M	–	1045
2021 Q2	$6.37M	Buy	+660,818	New	+$5.21M	0.03%	507

Other funds holding STXS

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

ITP

Iron Triangle Partners Cos Cob, Connecticut $875M AUM 49.85% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Calamos Advisors's STXS Position: Q3 2021 in Review

Calamos Advisors sold out of Stereotaxis (STXS) in Q3 2021, closing a stake of 660,818 shares — an estimated $6.37M sold.

Calamos Advisors first reported a position in STXS in Q2 2021 and held it in 1 quarter. The position peaked at $6.37M in Q2 2021. 104 funds tracked by Wall St. Rank hold STXS as of Q3 2021.

Calamos Advisors reported no remaining Stereotaxis position as of Q3 2021 after selling out during the quarter.
Calamos Advisors sold 660,818 Stereotaxis shares in Q3 2021, an estimated $6.37M.
Calamos Advisors first reported a position in Stereotaxis in Q2 2021 and held it in 1 quarter.
Calamos Advisors's Stereotaxis position peaked at $6.37M in Q2 2021.
104 funds tracked by Wall St. Rank held Stereotaxis as of Q3 2021.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.